Review for "Long‐Term Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes: Pooled 52‐Week Outcomes from the DEPICT‐1 and ‐2 Studies"
2017 ◽
Vol 19
(2)
◽
pp. 109-114
◽
Keyword(s):
2020 ◽
Vol 22
(9)
◽
pp. 1516-1526
◽
2020 ◽